Dates

Headlines

June 14, 2019

Regis Expands to 24-Hour Operations

Regis Technologies, a Chicago-based contract development and manufacturing organization focused on small molecule active pharmaceutical ingredients (API), is expanding its operations. To better serve our Custom Pharma clients, we are adding a third shift. This will allow us to run our manufacturing 24 hours a day, five days a week. […]
May 17, 2019

Meet Ron

Regis Technologies is proud to announce the addition of Ronald L. Mueller, Ph.D. to spearhead our newest offering of Solid State Chemistry (SSC). Dr. Mueller has more than 25 years in the pharmaceutical industry and over 20 years of preformulation and solid state chemistry experience. After earning his B.Sc. in […]
April 30, 2019

Regis Technologies’ 2019 FDA Inspection Yields NAI Classification

Regis Technologies, Inc. reports the successful outcome of its routine U.S. Food & Drug Administration (FDA) inspection which found no objectionable findings. This marks the fourth consecutive, impeccable inspection for Regis and demonstrates its commitment to a standard of excellence in quality and compliance in the pharmaceutical industry. The inspection […]
January 30, 2019

Analyst Of The Year 2018

Congratulations to Michael Kruk for receiving the Analyst of the Year Award for 2018. Michael is an alumnus of Northeastern Illinois University with a Bachelor of Science in Chemistry. He has industry experience via an internship program at Abbvie & Abbott Labs. As an interning chemist there, he received the […]
December 18, 2018

President’s Award Winner 2018

Each year, Regis’ President & CEO recognizes one employee for outstanding performance. Amongst many deserving nominees, Louis Glunz was honored to present Iram Ruiz with the 2018 President’s Award at our company holiday party on December 8th. Iram joined Regis in late 2013 as a Production Technician. Utilizing excellent problem-solving […]
November 20, 2018

Meet Eric

Regis is happy to announce a new addition to its Process Chemistry department, Eric Buck, Ph.D. Eric joined our team in October 2018 as a Process Development Chemist III. His main responsibility is to safely develop and scale up APIs for commercial manufacturing. Eric graduated from the University of Minnesota […]
September 20, 2018

Breakfast Seminar Series On Controlling Impurities

This fall, Regis Custom Pharma will host a series of breakfast seminars on “Speeding Drug Development through State-of-the-Art Impurity Control Strategies.” Guest speaker Steven Baertschi, Ph.D. will deliver the technical talks, which are open to the public, in Morton Grove (10/17), South San Francisco (10/31), and San Diego (11/1). Registration […]
September 17, 2018

Biggest Losers Win Big at Regis

Over the past three years, Regis employees have collectively lost hundreds of pounds by participating in our Biggest Loser contests. This summer, we finished our fifth season. Four teams competed, and the winning team lost 5% of its initial body weight. The contest was started from an employee suggestion and […]
August 6, 2018

Privacy Policy Updated

In compliance with GDPR standards, Regis has updated its Privacy Policy. Our site now uses cookies, and thus the following has been added to our policy: Cookies A cookie is a small file placed on your computer or device when you visit a website.  We use cookies for various functions, including […]
July 23, 2018

Meet Nathan

Congratulations to Nathaniel Kuffel for his promotion to Quality Control Chem II. Nathan holds a Bachelor’s degree in analytical chemistry and Master’s of Science from DePaul University. He earned his Master’s in 2015 while simultaneously gaining industry experience as an intern and research assistant at Perkin Elmer. Shortly after graduating […]
June 22, 2018

Dr. Louis J. Glunz III & the Founding of Regis

Louis J. Glunz III, Ph.D., was born on June 23, 1930. He founded Regis in 1956 and remains our Chairman today. Regis is a family-owned and operated business, a Glunz tradition since 1888. Dr. Glunz and his father would experiment together in a laboratory on the building’s third floor that […]
November 22, 2016

Regis Technologies Honored as Family Business of the Year

The Family Business Center at Loyola University Chicago’s Quinlan School of Business recently named Regis Technologies, Inc., the winner of the 2016 Illinois Family Business of the Year Award in the medium category (50-250 employees). Regis Technologies is a privately owned family-run business that has become a world-class leader in […]
August 4, 2015

Potent Compound Suite for Small Molecule Oncologicals

Regis Technologies is announcing their entry into the oncology market with the start up of the new Potent Compound Suite (PCS). The PCS allows Regis, a Chicago-based contract manufacturing organization (CMO), to target small molecule oncologicals and linker payload projects for antibody drug conjugates. Regis is a CMO operating a […]
May 8, 2015

Containment Performance Verification of the Potent Compound Suite Using Surrogate Monitoring

As part of commissioning of the Regis’ Potent Compound Suite 1 (PCS1), an industrial hygiene monitoring was performed by Safebridge Consultants, Inc., on March 4 and 5 of 2015 with the purpose to evaluate the containment performance of the facility. Based on the occupational exposure limits (OELs) of the future […]
March 6, 2015

Surrogate Powder Testing on Potent Compound Suite 1

With almost two years of planning and construction complete, Regis Technologies’ Potent Compound Suite 1 (PCS1) is in testing. On March 4th and 5th, an expert independent lab, Safebridge Consultants, Inc., performed a surrogate powder study on PCS1, in order to evaluate the containment capability of the suite and to […]